SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document
 

Domain Names
ZOHYDROERCOVERAGE.COM
ZOHYDROERHCP.COM
ZOHYDROERREMS.COM
ZOHYDRO-ER-REMS.COM
ZOHYDROERREMS.ORG
ZOHYDRO-ER-REMS.ORG
ZOHYDROHCP.COM
ZOHYDROREMS.COM
ZOHYRDO.COM
ZUTRIPRO.COM
ZYBERPHAR.COM
ZYBERPHARMACEUTICALS.COM
ZYBERRX.COM

IP Licenses

 

Pernix Therapeutics

 

1.Product License and Distribution Agreement dated as of August 19, 2014, by and between Pernix Ireland Limited (f/k/a Worrigan Limited) and Pernix Therapeutics, LLC.

 

2.Product License and Distribution Agreement dated as of April 24, 2015, by and between Ferrimill Limited and Pernix Therapeutics, LLC.

 

3.Settlement and License Agreement dated January 26, 2018 by and among Pernix Ireland Pain DAC, Pernix Therapeutics, LLC, Recro Gainesville LLC and Actavis Laboratories FL, Inc.

 

4.Settlement Agreement dated September 29, 2016 by and between Recro Gainesville LLC and Alvogen Malta Operations Ltd.

 

PERNIX SLEEP, INC.

 

1.License Agreement dated August 25, 2003 by and between ProCom One and Somaxon.

 

2.Amended and Restated License Agreement between Somaxon and ProCom dated September 15, 2010.

 

3.License Agreement dated June 7, 2011, by and between Somaxon and Paladin Labs Inc.

 

4.License Agreement dated April 26, 2012, by and between Somaxon and CJ CheilJedang Corporation assigned from CJ Cheiljedang Corporation to CJ HealthCare Corporation on April 1, 2014, then assigned to Kolmar Korea Co., Ltd. on February 20, 2018 under a share purchase agreement

 

5.Amendment Agreement dated as of March 2, 2015 by and between CJ HealthCare Corporation and Pernix Therapeutics Holdings, Inc.

 

6.Amendment No. 2 to the License Agreement dated as of February 15, 2016 by and between Pernix Therapeutics Holdings., Inc. and CJ HealthCare Corporation.

 

7.Settlement and License Agreement dated July 18, 2012, by and between Somaxon, ProCom One, Inc., Zydus Pharmaceuticals, Inc. and Cadila Healthcare Ltd.

 

Schedule 4.5

Page - 14